Literature DB >> 26681754

Regression of Atherosclerosis: The Journey From the Liver to the Plaque and Back.

Edward A Fisher1.   

Abstract

Cardinal events in atherogenesis are the retention of apolipoprotein B-containing lipoproteins in the arterial wall and the reaction of macrophages to these particles. My laboratory has been interested in both the cell biological events producing apolipoprotein B-containing lipoproteins, as well as in the reversal of the damage they cause in the plaques formed in the arterial wall. In the 2013 George Lyman Duff Memorial Lecture, as summarized in this review, I covered 3 areas of my past, present, and future interests, namely, the regulation of hepatic very low density lipoprotein production by the degradation of apolipoprotein B100, the dynamic changes in macrophages in the regression of atherosclerosis, and the application of nanoparticles to both image and treat atherosclerotic plaques.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  apolipoproteins B; atherosclerosis; autophagy; macrophages; nanoparticle

Mesh:

Substances:

Year:  2015        PMID: 26681754      PMCID: PMC4732981          DOI: 10.1161/ATVBAHA.115.301926

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  37 in total

1.  Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.

Authors:  Bernd Hewing; Saj Parathath; Tessa Barrett; Wing Ki Kellie Chung; Yaritzy M Astudillo; Tadateru Hamada; Bhama Ramkhelawon; Thomas C Tallant; Mohamed Shaif S Yusufishaq; Joseph A Didonato; Ying Huang; Jennifer Buffa; Stela Z Berisha; Jonathan D Smith; Stanley L Hazen; Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-09       Impact factor: 8.311

2.  Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques.

Authors:  Jonathan E Feig; Sajesh Parathath; James X Rong; Stephanie L Mick; Yuliya Vengrenyuk; Lisa Grauer; Stephen G Young; Edward A Fisher
Journal:  Circulation       Date:  2011-02-21       Impact factor: 29.690

3.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

Review 4.  High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies.

Authors:  Jonathan E Feig; Bernd Hewing; Jonathan D Smith; Stanley L Hazen; Edward A Fisher
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

5.  Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.

Authors:  Eugene Trogan; Jonathan E Feig; Snjezana Dogan; George H Rothblat; Véronique Angeli; Frank Tacke; Gwendalyn J Randolph; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-01       Impact factor: 11.205

Review 6.  The many intersecting pathways underlying apolipoprotein B secretion and degradation.

Authors:  Jeffrey L Brodsky; Edward A Fisher
Journal:  Trends Endocrinol Metab       Date:  2008-08-06       Impact factor: 12.015

7.  Rapid regression of atherosclerosis with MTP inhibitor treatment.

Authors:  Bernd Hewing; Saj Parathath; Christina K Mai; M Isabel Fiel; Liang Guo; Edward A Fisher
Journal:  Atherosclerosis       Date:  2013-01-01       Impact factor: 5.162

8.  Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases.

Authors:  Janet D Sparks; Colleen O'Dell; Jeffrey M Chamberlain; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2013-05-15       Impact factor: 3.575

9.  Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.

Authors:  Prabhakara R Nagareddy; Andrew J Murphy; Roslynn A Stirzaker; Yunying Hu; Shiquing Yu; Rachel G Miller; Bhama Ramkhelawon; Emilie Distel; Marit Westerterp; Li-Shin Huang; Ann Marie Schmidt; Trevor J Orchard; Edward A Fisher; Alan R Tall; Ira J Goldberg
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

10.  The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques.

Authors:  Janine M van Gils; Merran C Derby; Luciana R Fernandes; Bhama Ramkhelawon; Tathagat D Ray; Katey J Rayner; Sajesh Parathath; Emilie Distel; Jessica L Feig; Jacqueline I Alvarez-Leite; Alistair J Rayner; Thomas O McDonald; Kevin D O'Brien; Lynda M Stuart; Edward A Fisher; Adam Lacy-Hulbert; Kathryn J Moore
Journal:  Nat Immunol       Date:  2012-01-08       Impact factor: 25.606

View more
  24 in total

Review 1.  Atherosclerosis: Making a U Turn.

Authors:  Ira J Goldberg; Gaurav Sharma; Edward A Fisher
Journal:  Annu Rev Med       Date:  2020-01-27       Impact factor: 13.739

2.  Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.

Authors:  Paul A Mueller; Lin Zhu; Hagai Tavori; Katherine Huynh; Ilaria Giunzioni; John M Stafford; MacRae F Linton; Sergio Fazio
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

Review 3.  2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.

Authors:  Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-15       Impact factor: 8.311

4.  Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.

Authors:  Debapriya Basu; Yunying Hu; Lesley-Ann Huggins; Adam E Mullick; Mark J Graham; Tomasz Wietecha; Shelley Barnhart; Allison Mogul; Katharina Pfeiffer; Andreas Zirlik; Edward A Fisher; Karin E Bornfeldt; Florian Willecke; Ira J Goldberg
Journal:  Circ Res       Date:  2018-01-10       Impact factor: 17.367

5.  Liver X Receptor Nuclear Receptors Are Transcriptional Regulators of Dendritic Cell Chemotaxis.

Authors:  Susana Beceiro; Attila Pap; Zsolt Czimmerer; Tamer Sallam; Jose A Guillén; Germán Gallardo; Cynthia Hong; Noelia A-Gonzalez; Carlos Tabraue; Mercedes Diaz; Felix Lopez; Jonathan Matalonga; Annabel F Valledor; Pilar Dominguez; Carlos Ardavin; Cristina Delgado-Martin; Santiago Partida-Sanchez; Jose Luis Rodriguez-Fernandez; Laszlo Nagy; Peter Tontonoz; Antonio Castrillo
Journal:  Mol Cell Biol       Date:  2018-04-30       Impact factor: 4.272

Review 6.  The Ins and Outs of Myeloid Cells in Atherosclerosis.

Authors:  Ariane Schumski; Carla Winter; Yvonne Döring; Oliver Soehnlein
Journal:  J Innate Immun       Date:  2018-04-18       Impact factor: 7.349

Review 7.  Macrophages in vascular inflammation and atherosclerosis.

Authors:  Clement Cochain; Alma Zernecke
Journal:  Pflugers Arch       Date:  2017-02-06       Impact factor: 3.657

Review 8.  Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.

Authors:  MacRae F Linton; Vladimir R Babaev; Jiansheng Huang; Edward F Linton; Huan Tao; Patricia G Yancey
Journal:  Circ J       Date:  2016-10-08       Impact factor: 2.993

Review 9.  Cardiovascular Immunotherapy and the Role of Imaging.

Authors:  Eva Zupančič; Zahi A Fayad; Willem J M Mulder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11       Impact factor: 8.311

Review 10.  2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.

Authors:  Ira J Goldberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-01       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.